Skip to contentClarengateINTELLIGENCE
Companies/04974481

Oxford Biotherapeutics Ltd

Research and experimental development on biotechnology · Oxford

ActiveUnited KingdomIncorporated 2003Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · Group accounts

Net assets
−£4,185,709
Cash
£10,285,299
Turnover
—
Profit / loss
−£6,400,160
Current assets
—
Creditors < 1 year
—
Equity
−£4,185,709
Average employees
Not available

Balance-sheet trend

GBP · consolidated

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

4 periods
Reported figures2025-12-31Group2024-12-31Group2023-12-31Group2022-12-31Group
Balance sheet
Net assets−£4,185,709£2,075,035——
Equity−£4,185,709£2,075,035——
Assets
Intangible assets£6,620£0——
Property, plant & equipment£2,124,868£699,916——
Cash at bank£10,285,299£4,757,244£9,852,718£19,268,263
Profit & loss
Profit / loss−£6,400,160£3,560,161——
Source evidenceView filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 5 satisfied / released
Fixed · created 2019-08-28 · satisfied 2021-01-22
—
Satisfied
All Assets · created 2016-12-14 · satisfied 2021-01-22
—
Satisfied
All Assets · created 2015-06-03 · satisfied 2016-12-30
—
Satisfied
All Assets · created 2008-05-12 · satisfied 2015-04-23
All monies
Satisfied
Unknown · created 2005-06-14 · satisfied 2015-04-23
£38,187.50 DUE OR TO BECOME DUE FROM THE COMPANY TO THE CHARGEE
Satisfied